Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

om/> .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements, including summary statements relating to interim or preliminary results of clinical trials involving oral azacitidine. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the final results to differ significantly from the results summarized by such statements. Some of the clinical trials described in this release are being conducted by independent investigators and Pharmion does not control and cannot predict the final results of those trials. Top line or preliminary results may not be confirmed upon full analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of oral azacitidine may be discovered upon further analysis of clinical trial data and upon review and analysis of data from other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

# # #

------------------

(Back to top)

Exelixis Reports Comprehensive XL880 Phase I Data At ASCO

-Results support ongoing Phase II clinical development program-

CHICAGO, June 2 /PRNewswire-Fi
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:8/26/2014)... YORK and LONDON , ...   FDNA Inc. ( http://www.fdna.com ) and ... that they have partnered to offer, for the first ... through FDNA,s solutions. FDNA, developer of the ... integrate LMD,s award-winning collection into Face2Gene [ TM ...
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... , Aug. 26, 2014 Novira Therapeutics, ... for curative treatment of chronic hepatitis B virus (HBV) ... M.D., F.A.C.P., was appointed the Chair of its Scientific ... function as a Senior Advisor to the Company.  ... our SAB as Chair," said Christian Schade , ...
Breaking Medicine Technology:FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... 2011 Advanced Cell Diagnostics (ACD), a technological ... provider for biomedical image and data analysis, announce ... applications that will enable researchers to accurately quantify ... clinical specimen. The partnership will build on ACD,s ...
... 31, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... Phase IIb/III clinical trial of tasimelteon in patients with ... begin during the second half of 2011.  Tasimelteon is ... the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind ...
Cached Medicine Technology:Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 2Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis 3Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 2Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 3Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression 4
(Date:8/27/2014)... 2014 The use of ESAs to ... and may eliminate the need for blood transfusion and ... AllMed webinar, Dr. Zanhua Yi, board certified in hematology, ... medical necessity of erythropoiesis-stimulating agents (ESAs) in the treatment ... U.S. Food and Drug Administration (FDA) has approved three ...
(Date:8/27/2014)... Janice Holly Booth didn’t choose to travel ... her on an adventure outing to southern Utah where she’d ... harnesses and rappelling into mysterious, dark and potentially dangerous canyons. ... not my last,” she says. “I travelled alone for more ... edge, and experienced first-hand the kind of fear that keeps ...
(Date:8/27/2014)... The Connecticut Community for Addiction Recovery (CCAR) ... 2014, from 10:00 AM – 2:00 PM in Bushnell Park ... participants across the state to show their support for recovery ... state capitol. , Recovery Walks! is a celebration for the ... and other drugs as well as their families, friends, and ...
(Date:8/26/2014)... August 27, 2014 Hearing aids ... be hard for plan holders to determine what their hearing ... participating in several additional health plans and has published benefit ... assistance page . , The following is a list ... a participating provider: , NYSHIP/ NYS Empire Plan - Hearing ...
(Date:8/26/2014)... Emerging and established leaders who want to ... they serve – which includes their subordinates – should ... and read his latest must-read blog post titled ... , “Leadership is not a static role ... assumed,” commented Per Wickstrom, who blogs regularly on a ...
Breaking Medicine News(10 mins):Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2
... Across Nation Using Caregiverlist.com to Find Quality ... ... the nation,s online,destination dedicated to connecting seniors with quality senior care,choices, ... senior,in-home care services as the caregiving recruitment source for the,industry. Nearly ...
... are turning their attention to the normal cells that ... tumor growth might be stopped at the earliest opportunity. ... come from can provide critical insight into how cancers ... and Cancer Biology at Duke University Medical Center. "This ...
... aggressive childhood brain tumor known as medulloblastoma originates in ... on by a known mutant, cancer-causing oncogene, say researchers ... San Francisco (UCSF). , Reporting in the Aug. 12 ... they have uncovered new origins for these tumors from ...
... Medical receives Governor,s 2008 Excellence in Exporting Award (,E-Award,), official state ... Lieutenant Governor Lee Fisher present award to CSZ Chairman of the ... ... 2008 -- Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, ...
... In one of the first examinations of PSA screening in ... Prostate Center finds that one-fifth of men under age 50 ... prostate cancer in the previous year, yet only one in ... in the previous year. , Overall, that,s pretty good ...
... LANSING, Mich. The health of people who never ... counterparts, according to new research that suggests the practice ... , Hui Liu, assistant professor of sociology at Michigan ... sociologists since the 1970s have emphasized that marriage benefits ...
Cached Medicine News:Health News:Home Care Agencies Staffing Challenge Solved With Caregiverlist.com 2Health News:Key to treating cancer may be finding its original cell 2Health News:Childhood brain tumor traced to normal stem cells gone bad 2Health News:Childhood brain tumor traced to normal stem cells gone bad 3Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 2Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 3Health News:Study finds more PSA screening awareness needed among high-risk groups 2Health News:Health and marriage: The times they are a changin' 2
The three point staple, used for valgus tibial osteotomy, is easy and quick to fit, with a compact size compared with other existing systems....
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
... Radiopaque Bone Cement consists of ... sterile,ampule containing bone cement liquid ... a sterile polyethylene bag,containing bone ... pouch. The interiors of the ...
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Medicine Products: